Incyte president Pablo J. Cagnoni sells 2,642 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Pablo J. Cagnoni, Incyte Corporation’s President, Global Head of R&D, exercised options for 2,642 shares on November 16, 2026, at exercise prices of $61.18, $61.76, $64.25 and $71.93 per share. He also sold 2,642 shares: 877 at $121.98 and 1,765 at $120.46 per share. The transactions were reported under a Rule 10b5-1 plan.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to buy) F2 | 455 | $0.00 | $0.00 |
| Exercise | Employee Stock Option (right to buy) F3 | 422 | $0.00 | $0.00 |
| Exercise | Employee Stock Option (right to buy) F4 | 926 | $0.00 | $0.00 |
| Exercise | Employee Stock Option (right to buy) F5 | 839 | $0.00 | $0.00 |
| Exercise | Common Stock | 455 | $61.18 | $28K |
| Exercise | Common Stock | 422 | $61.76 | $26K |
| Exercise | Common Stock | 926 | $64.25 | $59K |
| Exercise | Common Stock | 839 | $71.93 | $60K |
| Sale | Common Stock | 877 | $121.98 | $107K |
| Sale | Common Stock F1 | 1,765 | $120.46 | $213K |
Footnotes (5)
- F1. This includes an aggregate of 183,200 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.
- F2. Beginning January 18, 2024, options become exercisable in 37 installments, with the first 25% vesting on July 14, 2024 and the remainder vesting monthly over three years.
- F3. The July 14, 2023 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
- F4. The July 15, 2024 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
- F5. Beginning January 17, 2025, options become exercisable in 37 installments, with the first 25% vesting on July 15, 2025 and the remainder vesting monthly over three years.
Key Figures
Key Terms
Employee Stock Option (right to buy) financial
restricted stock units financial
earned performance stock units financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What options did INCY executive Pablo J. Cagnoni exercise?
When do the exercised INCY options expire?
AI-generated analysis. How Rhea-AI works. Not financial advice.